Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity.

Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit.

Legacy patients are so-called because their opioid use behaviors express past, aggressive opioid prescribing by a clinician. Managing their pain and dependence justly is ethically complex.

Social work perspectives on whether prescribers should authorize opioid refills emphasize the importance of multidisciplinary approaches to patient self-determination.

Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective.

Label analysis is key to educating patients about risks of vitamin A-containing supplements.

Increase in dietary supplement use in the United States suggests a great need for clinicians to be aware of the range of their quality parameters.

Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences.

Consider the origins of America’s cosmetic and supplement industry and the advertising practices that sustain it.

Marissa Chaet Brykman joins Ethics Talk to discuss her article, coauthored with Dr Virginia Streusand Goldman, Dr Nandakumara Sarma, Dr Hellen A. Oketch-Rabah, Deborah Biswas and Dr Gabriel I. Giancaspro: “What Should Clinicians Know About Dietary Supplement Quality?”